{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:08:44Z","timestamp":1790651324049,"version":"4.1.0"},"reference-count":205,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SUR\/2022\/003323"],"award-info":[{"award-number":["SUR\/2022\/003323"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.bcp.2023.115723","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T11:38:54Z","timestamp":1690889934000},"page":"115723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Understanding the role of hyperglycemia and the molecular mechanism associated with diabetic neuropathy and possible therapeutic strategies"],"prefix":"10.1016","volume":"215","author":[{"given":"Mandeep","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Swarnkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balak","family":"Das Kurmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanshyam","family":"Das Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2023.115723_b0005","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.csbj.2016.12.005","article-title":"Machine learning and data mining methods in diabetes research","volume":"15","author":"Kavakiotis","year":"2017","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2015.19","article-title":"Type 2 diabetes mellitus","volume":"1","author":"DeFronzo","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bcp.2023.115723_b0015","series-title":"Quality of life of type 2 diabetic patients attending family medicine outpatient clinic of Suez Canal university hospitals in Ismailia city thesis","author":"Megahed","year":"2018"},{"key":"10.1016\/j.bcp.2023.115723_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bcp.2023.115723_b0025","series-title":"IDF Diabetes Atlas, tenth","author":"Federation","year":"2021"},{"key":"10.1016\/j.bcp.2023.115723_b0030","series-title":"Annales d'endocrinologie","article-title":"COVID-19 in diabetic patients: related risks and specifics of management","author":"Orioli","year":"2020"},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0035","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.dsx.2018.10.008","article-title":"Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention","volume":"13","author":"Tan","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-020-01200-7","article-title":"Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications","volume":"20","author":"Sun","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"issue":"8","key":"10.1016\/j.bcp.2023.115723_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107613","article-title":"Molecular complexities underlying the vascular complications of diabetes mellitus\u2013A comprehensive review","volume":"34","author":"Paul","year":"2020","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.bcp.2023.115723_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112563","article-title":"AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation","volume":"146","author":"Entezari","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2023.115723_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108932","article-title":"Rare diabetic neuropathies: It is not only distal symmetrical polyneuropathy","volume":"177","author":"Samakidou","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0060","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s12035-014-8706-9","article-title":"Peripheral nerve injury modulates neurotrophin signaling in the peripheral and central nervous system","volume":"50","author":"Richner","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2023.115723_b0065","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/B978-0-444-53480-4.00005-9","article-title":"Painful diabetic neuropathy: clinical aspects","volume":"126","author":"Didangelos","year":"2014","journal-title":"Handb. Clin. Neurol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0070","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s12020-016-1005-7","article-title":"The impact of glycemic variability on diabetic peripheral neuropathy","volume":"53","author":"Jin","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.bcp.2023.115723_b0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.diabres.2018.08.020","article-title":"A new look at painful diabetic neuropathy","volume":"144","author":"Sloan","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"2","key":"10.1016\/j.bcp.2023.115723_b0080","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s13410-020-00885-6","article-title":"Prevalence of peripheral neuropathy among type 2 diabetes mellitus patients in a rural health centre in South India","volume":"41","author":"Jasmine","year":"2021","journal-title":"Int. J. Diabetes Dev. Countries"},{"issue":"6","key":"10.1016\/j.bcp.2023.115723_b0085","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s13300-017-0295-y","article-title":"Diabetic neuropathy and gait: a review","volume":"8","author":"Alam","year":"2017","journal-title":"Diabetes therapy"},{"issue":"6","key":"10.1016\/j.bcp.2023.115723_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-015-0609-2","article-title":"Pathways in the diagnosis and management of diabetic polyneuropathy","volume":"15","author":"Kaku","year":"2015","journal-title":"Curr. Diab. Rep."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2023.115723_b0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1900\/RDS.2015.12.63","article-title":"Treating diabetic neuropathy: present strategies and emerging solutions","volume":"12","author":"Javed","year":"2015","journal-title":"The review of diabetic studies: RDS"},{"key":"10.1016\/j.bcp.2023.115723_b0100","series-title":"Diabetic Neuropathy and Clinical Practice","first-page":"141","article-title":"Clinical and Laboratory Measurements in Diabetic Neuropathies","author":"Kelkar","year":"2020"},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-78787-0","article-title":"Performance analysis of noninvasive electrophysiological methods for the assessment of diabetic sensorimotor polyneuropathy in clinical research: a systematic review and meta-analysis with trial sequential analysis","volume":"10","author":"Haque","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2023.115723_b0110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-3-030-36694-0_10","article-title":"Diabetes and the nervous system","author":"Vinik","year":"2020","journal-title":"Diabetes complications, comorbidities and related disorders"},{"issue":"6","key":"10.1016\/j.bcp.2023.115723_b0115","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.clinthera.2017.05.001","article-title":"Declining skeletal muscle function in diabetic peripheral neuropathy","volume":"39","author":"Parasoglou","year":"2017","journal-title":"Clin. Ther."},{"issue":"7","key":"10.1016\/j.bcp.2023.115723_b0120","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41574-021-00496-z","article-title":"Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy","volume":"17","author":"Sloan","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4093\/dmj.2018.0259","article-title":"Update on the impact, diagnosis and management of cardiovascular autonomic neuropathy in diabetes: what is defined, what is new, and what is unmet","volume":"43","author":"Spallone","year":"2019","journal-title":"Diabetes Metab. J."},{"issue":"10","key":"10.1016\/j.bcp.2023.115723_b0130","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jacc.2018.12.064","article-title":"Autonomic nervous system dysfunction: JACC focus seminar","volume":"73","author":"Goldberger","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115723_b0135","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2337\/db19-1046","article-title":"Risk factors for diabetic peripheral neuropathy and cardiovascular autonomic neuropathy in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study","volume":"69","author":"Braffett","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2023.115723_b0140","series-title":"Gastrointestinal Complications of Diabetes","first-page":"163","article-title":"Clinical Manifestations","author":"Bi\u0161\u0107anin","year":"2018"},{"key":"10.1016\/j.bcp.2023.115723_b0145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/B978-0-12-814572-2.00004-2","author":"Beadon","year":"2020","journal-title":"Multifocal motor neuropathy. Dysimmune Neuropathies"},{"key":"10.1016\/j.bcp.2023.115723_b0150","series-title":"Diabetic Neuropathy","first-page":"1","article-title":"Classification, risk factors, and clinical presentation diabetic neuropathy","author":"Yavuz","year":"2022"},{"key":"10.1016\/j.bcp.2023.115723_b0155","series-title":"Dysimmune Neuropathies","first-page":"199","article-title":"Cervical and lumbosacral radiculoplexus neuropathies","author":"Thaisetthawatkul","year":"2020"},{"key":"10.1016\/j.bcp.2023.115723_b0160","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-3-319-57901-6_7","article-title":"Peripheral Nervous System Metastases as Complications of Systemic Cancer","author":"Guidon","year":"2018","journal-title":"Cancer Neurology in Clinical Practice"},{"issue":"9","key":"10.1016\/j.bcp.2023.115723_b0165","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1212\/WNL.53.9.2113","article-title":"Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy","volume":"53","author":"Dyck","year":"1999","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2020.101565","article-title":"Lower extremity entrapment neuropathies","volume":"34","author":"Madani","year":"2020","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0175","article-title":"Uncommon compressive neuropathies of upper limbs","volume":"34","author":"J\u00fanior","year":"2020","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"51","key":"10.1016\/j.bcp.2023.115723_b0180","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5530\/ijper.51.1.13","article-title":"Characterization of peripheral neuropathy in rat model of type 2 diabetes","volume":"51","author":"Mehta","year":"2017","journal-title":"Indian J Pharm Educ Res"},{"key":"10.1016\/j.bcp.2023.115723_b0185","doi-asserted-by":"crossref","unstructured":"C. De Gregorio et al. Characterization of diabetic neuropathy progression in a mouse model of type 2 diabetes mellitus Biology open 7 9 2018 p. bio036830.","DOI":"10.1242\/bio.036830"},{"issue":"8","key":"10.1016\/j.bcp.2023.115723_b0190","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.tins.2013.04.008","article-title":"Novel pathogenic pathways in diabetic neuropathy","volume":"36","author":"Zenker","year":"2013","journal-title":"Trends Neurosci."},{"issue":"4","key":"10.1016\/j.bcp.2023.115723_b0195","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11892-013-0387-7","article-title":"Painful and painless diabetic neuropathy: one disease or two?","volume":"13","author":"Spallone","year":"2013","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.bcp.2023.115723_b0200","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/9781118924853.ch40","article-title":"Diabetic peripheral and autonomic neuropathy","author":"Ziegler","year":"2017","journal-title":"Textbook of diabetes"},{"issue":"2","key":"10.1016\/j.bcp.2023.115723_b0205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/diabetology2020004","article-title":"Diabetes Mellitus: insights from epidemiology, biochemistry, risk factors, diagnosis, complications and comprehensive management","volume":"2","author":"Alam","year":"2021","journal-title":"Diabetology"},{"issue":"5","key":"10.1016\/j.bcp.2023.115723_b0210","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pcd.2019.12.005","article-title":"Prevalence of peripheral neuropathy in patients with diabetes: A systematic review and meta-analysis","volume":"14","author":"Sun","year":"2020","journal-title":"Prim. Care Diabetes"},{"issue":"9","key":"10.1016\/j.bcp.2023.115723_b0215","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.2337\/dc17-0179","article-title":"Prevalence of and risk factors for diabetic peripheral neuropathy in youth with type 1 and type 2 diabetes: SEARCH for Diabetes in Youth Study","volume":"40","author":"Jaiswal","year":"2017","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.bcp.2023.115723_b0220","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s40200-020-00597-y","article-title":"Prevalence of peripheral neuropathy and associated pain in patients with diabetes mellitus: evidence from a cross-sectional study","volume":"19","author":"Baxi","year":"2020","journal-title":"J. Diabetes Metab. Disord."},{"issue":"6","key":"10.1016\/j.bcp.2023.115723_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-021-01387-3","article-title":"The prevalence of diabetic microvascular complications in China and the USA","volume":"21","author":"Lin","year":"2021","journal-title":"Curr. Diab. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-020-0534-5","article-title":"Prevalence of diabetic peripheral neuropathy in Africa: a systematic review and meta-analysis","volume":"20","author":"Shiferaw","year":"2020","journal-title":"BMC Endocr. Disord."},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-98565-w","article-title":"Prevalence of peripheral neuropathy defined by monofilament insensitivity in middle-aged and older adults in two US cohorts","volume":"11","author":"Hicks","year":"2021","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.bcp.2023.115723_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-019-1212-8","article-title":"Epidemiology of peripheral neuropathy and lower extremity disease in diabetes","volume":"19","author":"Hicks","year":"2019","journal-title":"Curr. Diab. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2023.115723_b0245","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/jns.12392","article-title":"Diabetic polyneuropathy: bridging the translational gap","volume":"25","author":"Kobayashi","year":"2020","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.bcp.2023.115723_b0250","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/B978-0-444-53480-4.00028-X","article-title":"Mechanisms of diabetic neuron damage: Molecular pathways","volume":"126","author":"Zochodne","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.bcp.2023.115723_b0255","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/B978-0-444-62627-1.00015-9","article-title":"Clinical description of toxic neuropathies","volume":"131","author":"Little","year":"2015","journal-title":"Handb. Clin. Neurol."},{"issue":"8","key":"10.1016\/j.bcp.2023.115723_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-019-0974-3","article-title":"Hereditary sensory and autonomic neuropathies: adding more to the classification","volume":"19","author":"Schwartzlow","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.bcp.2023.115723_b0265","unstructured":"Blaszkiewicz, M., The Importance of Brain-Adipose Communication for Metabolic Homeostasis. 2019: The University of Maine."},{"key":"10.1016\/j.bcp.2023.115723_b0270","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/B978-0-7020-4087-0.00051-6","article-title":"Diabetic neuropathy","volume":"120","author":"Charnogursky","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.bcp.2023.115723_b0275","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/674987","article-title":"Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets","author":"Sandireddy","year":"2014","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.bcp.2023.115723_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.05.031","article-title":"A review on protective role of genistein against oxidative stress in diabetes and related complications","volume":"310","author":"Weng","year":"2019","journal-title":"Chem. Biol. Interact."},{"issue":"4","key":"10.1016\/j.bcp.2023.115723_b0285","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12229-020-09231-1","article-title":"Oxidative stress and antioxidant metabolism under adverse environmental conditions: a review","volume":"87","author":"Garcia-Caparros","year":"2021","journal-title":"Bot. Rev."},{"issue":"4","key":"10.1016\/j.bcp.2023.115723_b0290","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3233\/JAD-131409","article-title":"Risk factors for development of dementia in a unique six-year cohort study. I. An exploratory, pilot study of involvement of the E4 allele of apolipoprotein E, mutations of the hemochromatosis-HFE gene, type 2 diabetes, and stroke","volume":"38","author":"Percy","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.bcp.2023.115723_b0295","article-title":"Interactions between reactive oxygen species and autophagy: Special issue: Death mechanisms in cellular homeostasis. Biochimica et Biophysica Acta (BBA)-Molecular","volume":"1868","author":"Redza-Dutordoir","year":"2021","journal-title":"Cell Res."},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0300","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2337\/diabetes.53.3.711","article-title":"Role of poly (ADP-ribose) polymerase activation in diabetic neuropathy","volume":"53","author":"Obrosova","year":"2004","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.bcp.2023.115723_b0305","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bbadis.2008.11.005","article-title":"Diabetes and the peripheral nerve","volume":"1792","author":"Obrosova","year":"2009","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"8","key":"10.1016\/j.bcp.2023.115723_b0310","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2337\/diabetes.50.8.1927","article-title":"Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve","volume":"50","author":"Coppey","year":"2001","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0315","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2337\/diabetes.52.1.165","article-title":"Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy","volume":"52","author":"Schmeichel","year":"2003","journal-title":"Diabetes"},{"issue":"21","key":"10.1016\/j.bcp.2023.115723_b0320","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1161\/01.CIR.0000038365.78031.9C","article-title":"Poly (ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity","volume":"106","author":"Szab\u00f3","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2023.115723_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101195","article-title":"Role of NAD+ in regulating cellular and metabolic signaling pathways","volume":"49","author":"Amjad","year":"2021","journal-title":"Molecular Metabolism"},{"issue":"5","key":"10.1016\/j.bcp.2023.115723_b0330","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrd1718","article-title":"Poly (ADP-ribose) polymerase and the therapeutic effects of its inhibitors","volume":"4","author":"Jagtap","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0335","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1007\/s11033-021-06285-1","article-title":"PARP overactivation in neurological disorders","volume":"48","author":"Arruri","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"17","key":"10.1016\/j.bcp.2023.115723_b0340","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1089\/scd.2015.0076","article-title":"Differentiation of human neural stem cells into motor neurons stimulates mitochondrial biogenesis and decreases glycolytic flux","volume":"24","author":"O'Brien","year":"2015","journal-title":"Stem Cells Dev."},{"issue":"11","key":"10.1016\/j.bcp.2023.115723_b0345","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s001250100001","article-title":"Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy","volume":"44","author":"Cameron","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2023.115723_b0350","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cbi.2017.01.021","article-title":"Phenolic compounds: The inhibition effect on polyol pathway enzymes","volume":"266","author":"Aslan","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2023.115723_b0355","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.biopha.2018.09.058","article-title":"Molecular pathways associated with oxidative stress in diabetes mellitus","volume":"108","author":"Ighodaro","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"17","key":"10.1016\/j.bcp.2023.115723_b0360","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.3390\/ijms21176275","article-title":"Pathophysiology of type 2 diabetes mellitus","volume":"21","author":"Galicia-Garcia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0365","first-page":"37","article-title":"C-peptide, Na+, K+-ATPase, and diabetes","volume":"5","author":"Vague","year":"2004","journal-title":"Exp. Diabesity Res."},{"issue":"11","key":"10.1016\/j.bcp.2023.115723_b0370","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.acvd.2020.06.006","article-title":"Myocardial glucotoxicity: Mechanisms and potential therapeutic targets","volume":"113","author":"Battault","year":"2020","journal-title":"Arch. Cardiovasc. Dis."},{"issue":"4","key":"10.1016\/j.bcp.2023.115723_b0375","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00726-010-0773-2","article-title":"Advanced glycation endproducts: from precursors to RAGE: round and round we go","volume":"42","author":"Ramasamy","year":"2012","journal-title":"Amino Acids"},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0380","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrneurol.2016.201","article-title":"Schwann cell interactions with axons and microvessels in diabetic neuropathy","volume":"13","author":"Gon\u00e7alves","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115723_b0385","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/cvr\/cvv263","article-title":"Impaired Hedgehog signalling-induced endothelial dysfunction is sufficient to induce neuropathy: implication in diabetes","volume":"109","author":"Chapouly","year":"2016","journal-title":"Cardiovasc. Res."},{"issue":"7","key":"10.1016\/j.bcp.2023.115723_b0390","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2337\/diabetes.53.7.1807","article-title":"Ciliary neurotrophic factor improves nerve conduction and ameliorates regeneration deficits in diabetic rats","volume":"53","author":"Mizisin","year":"2004","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0395","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1185\/03007995.2015.1128888","article-title":"Current and emerging therapies in the management of diabetic foot ulcers","volume":"32","author":"Karri","year":"2016","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bcp.2023.115723_b0400","doi-asserted-by":"crossref","unstructured":"Zhu, C., Aldose reductase inhibitors as potential therapeutic drugs of diabetic complications. Vol. 2. 2013: chapter.","DOI":"10.5772\/54642"},{"issue":"27","key":"10.1016\/j.bcp.2023.115723_b0405","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.2174\/13816128113199990310","article-title":"Current options and perspectives in the treatment of diabetic neuropathy","volume":"19","author":"Varkonyi","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.bcp.2023.115723_b0410","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/1389557515666150909143737","article-title":"Updates on aldose reductase inhibitors for management of diabetic complications and non-diabetic diseases","volume":"16","author":"Singh Grewal","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2023.115723_b0415","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1021\/jm500907a","article-title":"Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions","volume":"58","author":"Maccari","year":"2015","journal-title":"J. Med. Chem."},{"issue":"15","key":"10.1016\/j.bcp.2023.115723_b0420","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1016\/j.bmc.2019.06.024","article-title":"Synthesis and molecular modeling of novel non-sulfonylureas as hypoglycemic agents and selective ALR2 inhibitors","volume":"27","author":"Salem","year":"2019","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0425","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1573406414666180524082445","article-title":"Sorbinil, an aldose reductase inhibitor, in fighting against diabetic complications","volume":"15","author":"Huang","year":"2019","journal-title":"Med. Chem."},{"key":"10.1016\/j.bcp.2023.115723_b0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101799","article-title":"Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications","volume":"37","author":"Kang","year":"2020","journal-title":"Redox Biol."},{"issue":"12","key":"10.1016\/j.bcp.2023.115723_b0435","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.3390\/cells9122635","article-title":"Fructose metabolism in cancer","volume":"9","author":"Krause","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2023.115723_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2020.107512","article-title":"Mapping and refactoring pathway control through metabolic and protein engineering: The hexosamine biosynthesis pathway","volume":"40","author":"Coussement","year":"2020","journal-title":"Biotechnol. Adv."},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0445","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/18756417MTE0wNzg55","article-title":"Diabetic complications: an update on pathobiology and therapeutic strategies","volume":"18","author":"Nellaiappan","year":"2022","journal-title":"Curr. Diabetes Rev."},{"issue":"6","key":"10.1016\/j.bcp.2023.115723_b0450","doi-asserted-by":"crossref","first-page":"E1080","DOI":"10.1152\/ajpendo.1997.272.6.E1080","article-title":"Increased activity of the hexosamine synthesis pathway in muscles of insulin-resistant ob\/ob mice","volume":"272","author":"Buse","year":"1997","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0455","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2337\/diab.45.3.302","article-title":"Increased glutamine: fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM","volume":"45","author":"Yki-J\u00e4rvinen","year":"1996","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.bcp.2023.115723_b0460","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1210\/jc.2002-020440","article-title":"Muscle uridine diphosphate-hexosamines do not decrease despite correction of hyperglycemia-induced insulin resistance in type 2 diabetes","volume":"87","author":"Pouwels","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2023.115723_b0465","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3420187","article-title":"The oxidative stress and mitochondrial dysfunction during the pathogenesis of diabetic retinopathy","author":"Wu","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0470","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/ijms22010094","article-title":"Collateral Glucose-Utlizing Pathwaya in Diabetic Polyneuropathy","volume":"22","author":"Mizukami","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0475","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jfda.2016.11.006","article-title":"Macrophages in oxidative stress and models to evaluate the antioxidant function of dietary natural compounds","volume":"25","author":"Castaneda","year":"2017","journal-title":"J. Food Drug Anal."},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0480","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.redox.2013.07.005","article-title":"Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-\u03baB pathways in diabetic neuropathy","volume":"1","author":"Yerra","year":"2013","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.bcp.2023.115723_b0485","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2337\/diab.46.9.1497","article-title":"Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro","volume":"46","author":"Williams","year":"1997","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.bcp.2023.115723_b0490","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0495","first-page":"217","article-title":"Association of TGF-\u03b2 signaling in angiotensin II-induced PAI-1 mRNA upregulation in mesangial cells: role of PKC. Biochimica et Biophysica Acta (BBA)-Molecular","volume":"1449","author":"Motojima","year":"1999","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.bcp.2023.115723_b0500","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2337\/diabetes.48.4.855","article-title":"Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells","volume":"48","author":"Yerneni","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2023.115723_b0505","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.diabres.2019.01.002","article-title":"Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer","volume":"148","author":"Bellier","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bcp.2023.115723_b0510","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.freeradbiomed.2021.02.043","article-title":"Mitochondrial ROS and mitochondria-targeted antioxidants in the aged heart","volume":"167","author":"Bou-Teen","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0515","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.bbadis.2019.01.006","article-title":"Impact of advanced glycation end products (AGEs) signaling in coronary artery disease","volume":"1865","author":"Kosmopoulos","year":"2019","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2008.05.005","article-title":"Diabetic neuropathy: mechanisms to management","volume":"120","author":"Edwards","year":"2008","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0525","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1179\/174313206X152564","article-title":"Activation of the RAGE pathway: a general mechanism in the pathogenesis of polyneuropathies?","volume":"29","author":"Haslbeck","year":"2007","journal-title":"Neurol. Res."},{"issue":"10","key":"10.1016\/j.bcp.2023.115723_b0530","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1210\/jc.2004-0291","article-title":"Role of hexosamines in insulin resistance and nutrient sensing in human adipose and muscle tissue","volume":"89","author":"Pouwels","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"17","key":"10.1016\/j.bcp.2023.115723_b0535","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1161\/01.CIR.99.17.2239","article-title":"Effect of diabetes mellitus on formation of coronary collateral vessels","volume":"99","author":"Abac\u0131","year":"1999","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.bcp.2023.115723_b0540","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2337\/db07-0339","article-title":"Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy","volume":"57","author":"Toth","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2023.115723_b0545","series-title":"Mayo Clinic Proceedings","article-title":"Neuropathic pain: principles of diagnosis and treatment","author":"Gilron","year":"2015"},{"issue":"6","key":"10.1016\/j.bcp.2023.115723_b0550","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/2167702618781804","article-title":"Central sensitization: explanation or phenomenon?","volume":"6","author":"Van den Broeke","year":"2018","journal-title":"Clin. Psychol. Sci."},{"key":"10.1016\/j.bcp.2023.115723_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117459","article-title":"Schwann cells apoptosis is induced by high glucose in diabetic peripheral neuropathy","volume":"248","author":"Liu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2023.115723_b0560","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2021-10-2","article-title":"Diabetes: How to manage diabetic peripheral neuropathy","volume":"11","author":"Gandhi","year":"2022","journal-title":"Drugs in Context"},{"key":"10.1016\/j.bcp.2023.115723_b0565","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.biopha.2018.06.068","article-title":"Erythropoietin: A potential drug in the management of diabetic neuropathy","volume":"105","author":"Suarez-Mendez","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"252","key":"10.1016\/j.bcp.2023.115723_b0570","doi-asserted-by":"crossref","first-page":"p. re14","DOI":"10.1126\/stke.2522004re14","article-title":"Cell signaling and the genesis of neuropathic pain","volume":"2004","author":"Ji","year":"2004","journal-title":"Sci. STKE"},{"issue":"4","key":"10.1016\/j.bcp.2023.115723_b0575","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","article-title":"Microglial activation and chronic neurodegeneration","volume":"7","author":"Lull","year":"2010","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0580","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1533-2500.2010.00367.x","article-title":"The role of glia and the immune system in the development and maintenance of neuropathic pain","volume":"10","author":"Vallejo","year":"2010","journal-title":"Pain Pract."},{"key":"10.1016\/j.bcp.2023.115723_b0585","unstructured":"Abdel Salam Ibrahim Mohamed, S., A duo implication of miR-134 microRNA and LIM Kinase1 protein in neuropathic pain modulation of the rat spinal cord. 2012, Bordeaux 2."},{"issue":"11","key":"10.1016\/j.bcp.2023.115723_b0590","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/nm.2231","article-title":"Central mechanisms of pathological pain","volume":"16","author":"Kuner","year":"2010","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bcp.2023.115723_b0595","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jpain.2016.12.002","article-title":"Spinal D-serine increases PKC-dependent GluN1 phosphorylation contributing to the sigma-1 receptor-induced development of mechanical allodynia in a mouse model of neuropathic pain","volume":"18","author":"Choi","year":"2017","journal-title":"J. Pain"},{"issue":"10","key":"10.1016\/j.bcp.2023.115723_b0600","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.celrep.2016.11.024","article-title":"Potentiation of synaptic GluN2B NMDAR currents by Fyn kinase is gated through BDNF-mediated disinhibition in spinal pain processing","volume":"17","author":"Hildebrand","year":"2016","journal-title":"Cell Rep."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2023.115723_b0605","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pain.2006.09.014","article-title":"Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy","volume":"128","author":"Geha","year":"2007","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0610","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00018-008-8428-0","article-title":"Central mechanisms of experimental and chronic neuropathic pain: findings from functional imaging studies","volume":"66","author":"Seifert","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2023.115723_b0615","first-page":"34","article-title":"Brainstem pain-modulation circuitry and its plasticity in neuropathic pain: insights from human brain imaging investigations","volume":"2","author":"Mills","year":"2021","journal-title":"Frontiers in Pain Research"},{"key":"10.1016\/j.bcp.2023.115723_b0620","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.lfs.2017.09.033","article-title":"Research progress of mechanisms and drug therapy for neuropathic pain","volume":"190","author":"Yan","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2023.115723_b0625","first-page":"35","article-title":"Inflammatory mediators of neuropathic pain","volume":"17","author":"J\u00fanior","year":"2016","journal-title":"Revista Dor"},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0630","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.it.2016.10.001","article-title":"Nociceptor sensory neuron\u2013immune interactions in pain and inflammation","volume":"38","author":"Pinho-Ribeiro","year":"2017","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0635","first-page":"33","article-title":"Yoga as therapy for neurodegenerative disorders: a case report of therapeutic yoga for adrenomyeloneuropathy","volume":"13","author":"Muhammad","year":"2014","journal-title":"Integrative Medicine: A Clinician's Journal"},{"issue":"2","key":"10.1016\/j.bcp.2023.115723_b0640","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijcard.2014.04.117","article-title":"Protein kinase C in enhanced vascular tone in diabetes mellitus","volume":"174","author":"Kizub","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115723_b0645","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00204-015-1472-2","article-title":"Compromised MAPK signaling in human diseases: an update","volume":"89","author":"Kim","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0650","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.pain.2012.10.021","article-title":"Role of primary somatosensory cortex in the coding of pain","volume":"154","author":"Vierck","year":"2013","journal-title":"PAIN\u00ae"},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0655","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pain.2007.07.026","article-title":"The roles of sodium channels in nociception: implications for mechanisms of pain","volume":"131","author":"Cummins","year":"2007","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0660","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jpain.2005.09.006","article-title":"Sodium channels and mechanisms of neuropathic pain","volume":"7","author":"Devor","year":"2006","journal-title":"J. Pain"},{"issue":"9","key":"10.1016\/j.bcp.2023.115723_b0665","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/brain\/aws225","article-title":"Neurological perspectives on voltage-gated sodium channels","volume":"135","author":"Eijkelkamp","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2023.115723_b0670","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/bs.pmbts.2015.01.002","article-title":"Sensory TRP channels: the key transducers of nociception and pain","volume":"131","author":"Mickle","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.bcp.2023.115723_b0675","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fendo.2015.00088","article-title":"Identifying common genetic risk factors of diabetic neuropathies","volume":"6","author":"Witzel","year":"2015","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115723_b0680","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4172\/2155-6156.1000243","article-title":"Endothelial nitric oxide synthase gene polymorphism and the risk of diabetic neuropathy in Asian Indian patients with type 2 diabetes","volume":"4","author":"Shah","year":"2013","journal-title":"J Diabetes Metab"},{"issue":"10","key":"10.1016\/j.bcp.2023.115723_b0685","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.pain.2011.06.017","article-title":"A new definition of neuropathic pain","volume":"152","author":"Jensen","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.bcp.2023.115723_b0690","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nm.2750","article-title":"Methylglyoxal modification of Nav1. 8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy","volume":"18","author":"Bierhaus","year":"2012","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bcp.2023.115723_b0695","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00592-014-0582-2","article-title":"Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes","volume":"51","author":"Ciccacci","year":"2014","journal-title":"Acta Diabetol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115723_b0700","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/0003319712453645","article-title":"The \u03b54 allele of the APOE gene is associated with more severe peripheral neuropathy in type 2 diabetic patients","volume":"64","author":"Monastiriotis","year":"2013","journal-title":"Angiology"},{"issue":"5","key":"10.1016\/j.bcp.2023.115723_b0705","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/biomedicines9050573","article-title":"Treatment of painful diabetic neuropathy\u2014a narrative review of pharmacological and interventional approaches","volume":"9","author":"Gupta","year":"2021","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.bcp.2023.115723_b0710","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1464-5491.2007.02157.x","article-title":"International Diabetes Federation: a consensus on Type 2 diabetes prevention","volume":"24","author":"Alberti","year":"2007","journal-title":"Diabet. Med."},{"issue":"6","key":"10.1016\/j.bcp.2023.115723_b0715","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","article-title":"Diabetic neuropathy: clinical manifestations and current treatments","volume":"11","author":"Callaghan","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bcp.2023.115723_b0720","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8883736","article-title":"The Association of Fasting C-peptide with Corneal Neuropathy in Patients with Type 2 Diabetes","author":"Zuo","year":"2020","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.bcp.2023.115723_b0725","first-page":"348","article-title":"Painful diabetic neuropathy","author":"Peltier","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.bcp.2023.115723_b0730","first-page":"1","article-title":"Evidence-based treatment of painful diabetic neuropathy: A systematic review","author":"D\u2019Souza","year":"2022","journal-title":"Curr. Pain Headache Rep."},{"issue":"4","key":"10.1016\/j.bcp.2023.115723_b0735","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jama.279.4.287","article-title":"Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease","volume":"279","author":"Roose","year":"1998","journal-title":"J. Am. Med. Assoc."},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0740","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.clpt.2003.09.019","article-title":"Cyclic antidepressants and the risk of sudden cardiac death","volume":"75","author":"Ray","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2023.115723_b0745","doi-asserted-by":"crossref","unstructured":"Friedman, E.S. and I.M. Anderson, Managing depression in clinical practice. 2010: Springer Science & Business Media.","DOI":"10.1007\/978-1-84996-465-4"},{"issue":"Supplement_1","key":"10.1016\/j.bcp.2023.115723_b0750","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.2337\/dc17-S013","article-title":"10. Microvascular complications and foot care","volume":"40","author":"Association","year":"2017","journal-title":"Diabetes Care"},{"issue":"19","key":"10.1016\/j.bcp.2023.115723_b0755","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJM199205073261904","article-title":"Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy","volume":"326","author":"Max","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2023.115723_b0760","series-title":"Pharmacotherapy of depression","first-page":"33","article-title":"Clinical pharmacology and therapeuticsof antidepressants","author":"Ciraulo","year":"2011"},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0765","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jdiacomp.2014.08.008","article-title":"From guideline to patient: a review of recent recommendations for pharmacotherapy of painful diabetic neuropathy","volume":"29","author":"Ziegler","year":"2015","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.bcp.2023.115723_b0770","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2147\/JPR.S128655","article-title":"Evidence and consensus recommendations for the pharmacological management of pain in India","volume":"10","author":"Dureja","year":"2017","journal-title":"J. Pain Res."},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0775","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/amhs.amhs_7_18","article-title":"Neuropharmacological classification of antidepressant agents based on their mechanisms of action","volume":"6","author":"Fasipe","year":"2018","journal-title":"Archives of Medicine and Health Sciences"},{"issue":"8","key":"10.1016\/j.bcp.2023.115723_b0780","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s40266-015-0283-8","article-title":"Neuropathic pain due to small fiber neuropathy in aging: current management and future prospects","volume":"32","author":"Brouwer","year":"2015","journal-title":"Drugs Aging"},{"key":"10.1016\/j.bcp.2023.115723_b0785","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","volume":"1","author":"Lunn","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.bcp.2023.115723_b0790","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1526-4637.2006.00207.x","article-title":"Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study","volume":"7","author":"Raskin","year":"2006","journal-title":"Pain Med."},{"issue":"Supplement_1","key":"10.1016\/j.bcp.2023.115723_b0795","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc19-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142019","volume":"42","author":"Association","year":"2019","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0800","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.pain.2004.05.010","article-title":"Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study","volume":"110","author":"Rowbotham","year":"2004","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0805","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/00325481.2016.1147925","article-title":"Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics","volume":"128","author":"Khouzam","year":"2016","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.bcp.2023.115723_b0810","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.phrs.2016.09.021","article-title":"Increasing spinal 5-HT2A receptor responsiveness mediates anti-allodynic effect and potentiates fluoxetine efficacy in neuropathic rats. Evidence for GABA release","volume":"118","author":"Dupuis","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2023.115723_b0815","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2018.03.042","article-title":"Uses of fluoxetine in nociceptive pain management: A literature overview","volume":"829","author":"Barakat","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115723_b0820","unstructured":"Harrison, S., et al. A comparison of antidepressant medication alone and in conjunction with cognitive behavioral therapy for chronic idiopathic facial pain. in Proceedings of the 8th World Congress on Pain. 1997. INT ASSOC STUDY PAIN (IASP) PRESS."},{"issue":"2","key":"10.1016\/j.bcp.2023.115723_b0825","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pain.2008.04.012","article-title":"Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial","volume":"139","author":"Otto","year":"2008","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.bcp.2023.115723_b0830","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0304-3959(90)91157-E","article-title":"The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms","volume":"42","author":"Sindrup","year":"1990","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.bcp.2023.115723_b0835","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/clpt.1992.183","article-title":"The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy","volume":"52","author":"Sindrup","year":"1992","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2023.115723_b0840","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2165\/00003495-200767040-00006","article-title":"Diabetic painful neuropathy","volume":"67","author":"Chong","year":"2007","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b0845","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40122-017-0091-4","article-title":"Pharmacotherapy for neuropathic pain: a review","volume":"6","author":"Fornasari","year":"2017","journal-title":"Pain Ther."},{"key":"10.1016\/j.bcp.2023.115723_b0850","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-94-017-7537-3_9","article-title":"Advances in the treatment of neuropathic pain","author":"Xu","year":"2016","journal-title":"Translational Research in Pain and Itch"},{"issue":"4","key":"10.1016\/j.bcp.2023.115723_b0855","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpain.2004.12.007","article-title":"Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial","volume":"6","author":"Richter","year":"2005","journal-title":"J. Pain"},{"key":"10.1016\/j.bcp.2023.115723_b0860","series-title":"Seminars in cell & developmental biology","article-title":"The role of sodium channels in neuropathic pain","author":"Rogers","year":"2006"},{"issue":"11","key":"10.1016\/j.bcp.2023.115723_b0865","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1080\/14656566.2018.1501026","article-title":"Topical drug therapeutics for neuropathic pain","volume":"19","author":"Coderre","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"issue":"12","key":"10.1016\/j.bcp.2023.115723_b0870","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11940-015-0381-2","article-title":"Treatment of neuropathic pain","volume":"17","author":"Mendlik","year":"2015","journal-title":"Curr. Treat. Options. Neurol."},{"key":"10.1016\/j.bcp.2023.115723_b0875","article-title":"5% lidocaine medicated plaster in painful diabetic peripheral neuropathy (DPN): a systematic review","author":"Wolff","year":"2010","journal-title":"Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]"},{"issue":"4","key":"10.1016\/j.bcp.2023.115723_b0880","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00044011-200929040-00002","article-title":"Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy","volume":"29","author":"Baron","year":"2009","journal-title":"Clin. Drug Invest."},{"issue":"7","key":"10.1016\/j.bcp.2023.115723_b0885","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/dmrr.1225","article-title":"Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management","volume":"27","author":"Tesfaye","year":"2011","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"4","key":"10.1016\/j.bcp.2023.115723_b0890","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s40265-020-01259-2","article-title":"Treating pain in diabetic neuropathy: current and developmental drugs","volume":"80","author":"Alam","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.bcp.2023.115723_b0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154867","article-title":"Management of diabetic neuropathy","volume":"123","author":"Cernea","year":"2021","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.bcp.2023.115723_b0900","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neurol.2020.01.361","article-title":"Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations","volume":"176","author":"Moisset","year":"2020","journal-title":"Rev. Neurol."},{"issue":"11","key":"10.1016\/j.bcp.2023.115723_b0905","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1586\/14737175.2015.1101347","article-title":"Topical amitriptyline and ketamine for the treatment of neuropathic pain","volume":"15","author":"Mercadante","year":"2015","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bcp.2023.115723_b0910","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejphar.2015.08.015","article-title":"Effect of combination therapy consisting of enalapril, \u03b1-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat\/low dose streptozotocin treated rat","volume":"765","author":"Davidson","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115723_b0915","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s12020-020-02473-4","article-title":"Non-glucose risk factors in the pathogenesis of diabetic peripheral neuropathy","volume":"70","author":"Lee","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.bcp.2023.115723_b0920","series-title":"Pain","first-page":"911","article-title":"Diabetic peripheral neuropathy","author":"Watterworth","year":"2019"},{"issue":"7","key":"10.1016\/j.bcp.2023.115723_b0925","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/jphp.13241","article-title":"Treatment of diabetic peripheral neuropathy: a review","volume":"72","author":"Khdour","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115723_b0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112717","article-title":"Progress in the treatment of diabetic peripheral neuropathy","volume":"148","author":"Yang","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"10353","key":"10.1016\/j.bcp.2023.115723_b0935","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0140-6736(22)01472-6","volume":"400","author":"Tesfaye","year":"2022","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bcp.2023.115723_b0940","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrd3673","article-title":"Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain","volume":"11","author":"Roques","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.bcp.2023.115723_b0945","doi-asserted-by":"crossref","first-page":"p. BIO52","DOI":"10.1167\/iovs.16-21291","article-title":"Cibinetide improves corneal nerve fiber abundance in patients with sarcoidosis-associated small nerve fiber loss and neuropathic pain","volume":"58","author":"Culver","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bcp.2023.115723_b0950","series-title":"Precision Medicine in Diabetes: A Multidisciplinary Approach to an Emerging Paradigm","first-page":"171","article-title":"Precision Medicine for Diabetic Neuropathy","author":"Davalos","year":"2022"},{"key":"10.1016\/j.bcp.2023.115723_b0955","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6656863","article-title":"Pharmacotherapeutic options for managing neuropathic pain: a systematic review and meta-analysis","volume":"2021","author":"Di Stefano","year":"2021","journal-title":"Pain Res. Manag."},{"key":"10.1016\/j.bcp.2023.115723_b0960","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1097\/01.j.pain.0000460358.01998.15","article-title":"Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms?","volume":"156","author":"Attal","year":"2015","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.bcp.2023.115723_b0965","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/wvn.12097","article-title":"Effects of yoga on stress, stress adaption, and heart rate variability among mental health professionals\u2014A randomized controlled trial","volume":"12","author":"Lin","year":"2015","journal-title":"Worldviews Evid. Based Nurs."},{"key":"10.1016\/j.bcp.2023.115723_b0970","series-title":"International handbook of occupational therapy interventions","first-page":"837","article-title":"Prevention and health promotion in occupational therapy: From concepts to interventions","author":"Filiatrault","year":"2015"},{"issue":"2","key":"10.1016\/j.bcp.2023.115723_b0975","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ctcp.2015.02.002","article-title":"Effects of yoga on brain waves and structural activation: A review","volume":"21","author":"Desai","year":"2015","journal-title":"Complement. Ther. Clin. Pract."},{"issue":"4","key":"10.1016\/j.bcp.2023.115723_b0980","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4103\/0972-2327.104328","article-title":"The therapeutic value of yoga in neurological disorders","volume":"15","author":"Mishra","year":"2012","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115723_b0985","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s11136-013-0602-7","article-title":"Effect of aerobic exercise on quality of life in population with diabetic peripheral neuropathy in type 2 diabetes: a single blind, randomized controlled trial","volume":"23","author":"Dixit","year":"2014","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.bcp.2023.115723_b0990","doi-asserted-by":"crossref","first-page":"216","DOI":"10.11154\/pain.30.216","article-title":"Mechanisms and effects of forced and voluntary exercises on exercise-induced hypoalgesia in neuropathic pain model mice","volume":"30","author":"Kami","year":"2015","journal-title":"Pain Res"},{"issue":"2","key":"10.1016\/j.bcp.2023.115723_b0995","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.bbr.2010.11.005","article-title":"Long-term voluntary wheel running is rewarding and produces plasticity in the mesolimbic reward pathway","volume":"217","author":"Greenwood","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"5","key":"10.1016\/j.bcp.2023.115723_b1000","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jdiacomp.2014.04.007","article-title":"Exercise improves gait, reaction time and postural stability in older adults with type 2 diabetes and neuropathy","volume":"28","author":"Morrison","year":"2014","journal-title":"J. Diabetes Complications"},{"issue":"5","key":"10.1016\/j.bcp.2023.115723_b1005","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.apmr.2014.01.003","article-title":"Investigating the role of backward walking therapy in alleviating plantar pressure of patients with diabetic peripheral neuropathy","volume":"95","author":"Zhang","year":"2014","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_b1010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jdiacomp.2013.08.008","article-title":"Physical activity, glycemic control, and diabetic peripheral neuropathy: A national sample","volume":"28","author":"Loprinzi","year":"2014","journal-title":"J. Diabetes Complications"},{"issue":"11","key":"10.1016\/j.bcp.2023.115723_bib1011","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010567","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","volume":"2013","author":"Wiffen","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.bcp.2023.115723_bib1012","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1742-7843.2005.pto_96696601.x","article-title":"Antidepressants in the Treatment of Neuropathic Pain","volume":"96","author":"Sindrup","year":"2005","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115723_bib1013","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.35632","article-title":"Trends in Pain Medication Initiation Among Patients With Newly Diagnosed Diabetic Peripheral Neuropathy, 2014-2018","volume":"4","author":"Fan","year":"2021","journal-title":"JAMA Network Open"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223003143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223003143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:55:17Z","timestamp":1757771717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223003143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":205,"alternative-id":["S0006295223003143"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115723","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the role of hyperglycemia and the molecular mechanism associated with diabetic neuropathy and possible therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115723"}}